Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year  | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| JPMorgan Chase | JPMorgan Chase | financial services | toxic securities abuses | 2013 | DOJ | $13,000,000,000 |
| Deutsche Bank AG | Deutsche Bank | financial services | toxic securities abuses | 2013 | FHFA | $1,925,000,000 |
| Bank of America | Bank of America | financial services | toxic securities abuses | 2013 | FHFA | $10,350,000,000 |
| SAC Capital | insider trading | 2013 | USAO | $1,800,000,000 | ||
| JPMorgan Chase | JPMorgan Chase | financial services | toxic securities abuses | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,066,000,000 |
| DePuy Orthopaedics, Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
| Toyota Motor Corp. | Toyota | motor vehicles | product safety violation | 2013 | private lawsuit-federal | $1,600,000,000 |
| Knauf Plasterboard Tianjin | Knauf | building materials | product safety violation | 2013 | private lawsuit-federal | $1,000,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| BP Exploration and Production Inc. | BP | oil and gas | environmental violation | 2012 | DOJ | $4,000,000,000 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2012 | DOJ | $10,956,600,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | mortgage abuses | 2012 | DOJ | $5,333,600,000 |
| Wells Fargo & Company | Wells Fargo | financial services | mortgage abuses | 2012 | DOJ | $5,342,200,000 |
| Citigroup Inc. | Citigroup | financial services | mortgage abuses | 2012 | DOJ | $2,202,000,000 |
| HSBC Holdings plc HSBC Bank USA N.A. | HSBC | financial services | anti-money-laundering deficiencies | 2012 | DOJ_CRIMINAL | $1,256,000,000 |
| Bank of America | Bank of America | financial services | investor protection violation | 2012 | MULTI-AG | $2,430,000,000 |
| Bank of America | Bank of America | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,382,415,075 |
| JPMorgan Chase | JPMorgan Chase | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,121,188,661 |
| Wells Fargo | Wells Fargo | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,005,233,716 |
| BP | BP | oil and gas | environmental violation | 2012 | private lawsuit-federal | $7,800,000,000 |
| Bank of America | Bank of America | financial services | toxic securities abuses | 2011 | FHFA | $1,300,000,000 |
| Bank of America | Bank of America | financial services | toxic securities abuses | 2011 | FHFA | $1,520,000,000 |
| Countrywide Financial Corporation | Bank of America | financial services | mortgage abuses | 2010 | MULTI-AG | $3,004,100,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Wells Fargo | Wells Fargo | financial services | investor protection violation | 2009 | CA-AG | $1,400,000,000 |
| Banc of America Securities LLC | Bank of America | financial services | investor protection violation | 2008 | MULTI-AG | $4,550,000,000 |
| Citigroup Global Markets, Inc. and Citi Smith Barney | Citigroup | financial services | investor protection violation | 2008 | MULTI-AG | $7,100,000,000 |
| Countrywide Home Loans | Bank of America | financial services | mortgage abuses | 2008 | MULTI-AG | $8,680,000,000 |
| Deutsche Bank Securities, Inc. and Deutsche Bank AG | Deutsche Bank | financial services | investor protection violation | 2008 | MULTI-AG | $3,348,333,333 |
| Goldman Sachs Group, Inc. | Goldman Sachs | financial services | investor protection violation | 2008 | MULTI-AG | $3,355,833,333 |
| JP Morgan Chase & Co. | JPMorgan Chase | financial services | investor protection violation | 2008 | MULTI-AG | $3,525,000,000 |
| Merrill Lynch & Co. | Bank of America | financial services | investor protection violation | 2008 | MULTI-AG | $3,458,333,333 |
| Morgan Stanley | Morgan Stanley | financial services | investor protection violation | 2008 | MULTI-AG | $3,535,000,000 |
| UBS Securities LLC and UBS Financial Services, Inc. | UBS | financial services | investor protection violation | 2008 | MULTI-AG | $11,150,000,000 |
| American Electric Power | American Electric Power | utilities and power generation | environmental violation | 2007 | EPA | $4,675,000,000 |
| American Electric Power | American Electric Power | utilities and power generation | environmental violation | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,675,000,000 |
| Merck & Co., Inc. | Merck | pharmaceuticals | tax violations | 2007 | IRS | $2,300,000,000 |
| Merck & Co. | Merck | pharmaceuticals | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $4,850,000,000 |
| American International Group | American International Group | financial services | price-fixing or anti-competitive practices | 2006 | NY-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,619,000,000 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| Exxon Corporation | Exxon Mobil | oil and gas | price-fixing or anti-competitive practices | 2006 | private lawsuit-federal | $1,075,000,000 |
| Microsoft Corporation | Microsoft | information technology | price-fixing or anti-competitive practices | 2006 | private lawsuit-state | $1,100,000,000 |
| Ohio Edison Company | FirstEnergy | utilities and power generation | environmental violation | 2005 | EPA | $1,133,500,000 |
| Enron | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $1,520,000,000 | ||
| Mastercard International Inc. | MasterCard | financial services | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $1,025,000,000 |
| Visa USA | Visa | financial services | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $2,025,000,000 |
| Virginia Electric Power Co. | Dominion Energy | utilities and power generation | environmental violation | 2003 | EPA | $1,219,200,000 |
| El Paso Corporation | Kinder Morgan | pipelines | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $1,450,000,000 |
| Sulzer Medica | Zimmer Biomet | medical equipment and supplies | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $1,000,000,000 |
| American Home Products | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $3,750,000,000 |
| U.S. Tobacco Co. | Altria | tobacco | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $1,050,000,000 |
| Cinergy Corporation | Duke Energy | utilities and power generation | environmental violation | 2000 | EPA | $1,430,000,000 |
